Associate Director, Neuroscience, Clinical Biomarker, Late Phases, Translational Medicine at Bristol-Myers Squibb

Winter Garden, Florida, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, BiotechnologyIndustries

Requirements

Deep training and education in Neuroscience
Recognized expertise in translational biomarkers in neuroscience space
Experience in late stage drug development and activities required for and related to clinical trial initiation, maintenance and completion
Strong verbal and written communication skills
Experience in interacting with CROs and TLs to manage projects and timelines
Proven scientific/leadership expertise (working in teams, mentoring people, managing projects)
Accountable for timelines and deliverables
Prioritizes risks and implements contingency plans
Communicates regularly; prepares and delivers presentations within the department, to governance and senior leadership bodies, and externally as requested
Recognizes cross-functional issues and communicates within the larger organization. Provides expert guidance to multi-disciplinary teams and senior management. Has a track record of delivering results, driving contin

Responsibilities

Designs and implements program-specific late development biomarker/translational plans, responsible for aiding in creation of clinical protocols, SAPs, SOWs, lab manual, and interfacing with CRO for execution of services, in conjunction with Biospecimen Operations and Procurement
Determines appropriate assays and vendors for clinical biomarkers, and manages outsourcing of biomarker assay development and validation partnering with Translational Sciences colleagues when applicable
Manages clinical biomarker data delivery and analysis and associated timelines by working with relevant internal functions and CROs
Prepares and delivers internal and external translational/biomarker presentations
Maintains timelines for biomarker data related publication through interaction with Medical Communications and Publication team as needed
Keeps up-to-date on relevant scientific/technical literature in order to applying external knowledge to internal research programs as appropriate and acts as a subject-matter expert within the team to critically evaluate the literature regarding the asset and disease biology
Works with TM laboratory scientists and academic TLs to address nonclinical translational questions
Participates in post-hoc biomarker analysis and publication efforts
Supports regulatory submissions and regulatory interactions as needed

Skills

Neuroscience

Biomarkers

Translational Medicine

Clinical Protocols

Statistical Analysis Plans

Statements of Work

CRO Management

Biospecimen Management

Pharmacology

Clinical Trials

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free